New Data Presented at ACR Meeting Demonstrates Colcrys (Colchicine …

This Phase III, randomized , double-blind, placebo- controlled , parallel group study represents a secondary analysis of the previously presented AGREE trial data. A total of 184 patients having a clinical diagnosis of gout according to ACR …

Read the original here:
New Data Presented at ACR Meeting Demonstrates Colcrys (Colchicine …

No comments yet.

TOP